News :: Community Pharmacist Aid

FDA approves the first antihemophilic factor, Fc fusion protein for patients with Hemophilia A

06/06/2014 11:57

FDA approves the first antihemophilic factor, Fc fusion protein for patients with Hemophilia A The U.S. Food and Drug Administration today approved Eloctate, Antihemophilic Factor (Recombinant), Fc fusion protein, for use in adults and children who have Hemophilia...

FDA approves first generic versions of celecoxib

30/05/2014 11:59

FDA approves first generic versions of celecoxib The U.S. Food and Drug Administration today approved the first generic versions of Celebrex (celecoxib) capsules, a treatment for rheumatoid arthritis, osteoarthritis, short-term (acute) pain, and other...

FDA approves first implantable wireless device with remote monitoring to measure pulmonary artery pressure in certain heart failure patients

28/05/2014 12:00

FDA approves first implantable wireless device with remote monitoring to measure pulmonary artery pressure in certain heart failure patients The U.S. Food and Drug Administration today approved the CardioMEMS HF System that measures the pulmonary artery (PA)...

FDA targets illegal online pharmacies in globally coordinated action

22/05/2014 12:03

FDA targets illegal online pharmacies in globally coordinated action The U.S. Food and Drug Administration, in partnership with other federal and international agencies, took action this week against websites that sell potentially dangerous, unapproved prescription...

FDA approves Entyvio to treat ulcerative colitis and Crohn's disease

20/05/2014 12:05

FDA approves Entyvio to treat ulcerative colitis and Crohn's disease The U.S. Food and Drug Administration today approved Entyvio (vedolizumab) injection to treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe...

FDA approves Zontivity to reduce the risk of heart attacks and stroke in high-risk patients

08/05/2014 12:06

FDA approves Zontivity to reduce the risk of heart attacks and stroke in high-risk patients The U.S. Food and Drug Administration today approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore the...

FDA approves Sylvant for rare Castleman’s disease

23/04/2014 06:59

FDA approves Sylvant for rare Castleman’s disease The U.S. Food and Drug Administration today approved Sylvant (siltuximab) to treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes). MCD causes an abnormal overgrowth of...

FDA approves Cyramza for stomach cancer

21/04/2014 07:04

FDA approves Cyramza for stomach cancer The U.S. Food and Drug Administration today approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the...

FDA approves Ragwitek for short ragweed pollen allergies

17/04/2014 07:07

FDA approves Ragwitek for short ragweed pollen allergies The U.S. Food and Drug Administration today approved Ragwitek, the first allergen extract administered under the tongue (sublingually) to treat short ragweed pollen induced allergic rhinitis (hay fever), with or without...

FDA approves Tanzeum to treat type 2 diabetes

15/04/2014 07:10

FDA approves Tanzeum to treat type 2 diabetes The U.S. Food and Drug Administration today approved Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. Type 2 diabetes affects approximately 24 million...

News